Tumor Immunology and Immunotherapy
Suzhou Dushu Lake Conference Center
No.299 Qiyue Road SIP/ Suzhou
Jiangsu Province, China
We are pleased to announce the Cold Spring Harbor Asia conference on Tumor Immunology and Immunotherapy, which will be held at the Suzhou Dushu Lake Conference Center in Suzhou, China, located approximately 60 miles west of Shanghai. The conference will begin at 7:00pm on the evening of Monday October 28, and will conclude after the lunch on Friday November 1, 2013.

Schedule of Presentations:

Monday, October 28, 2013
09:00:00 Engineering Immunologic Protection and Therapy David Baltimore
10:00:00 TNFalpha and TLR3/4 induced necrosis pathway Xiaodong Wang
11:00:00 Cancer cells hijack immune cells for dissemination and metastasis. Jean-Pierre Abastado
12:00:00 Mechanistic insights in T-cell costimulation by the CD27/CD70 pathway encourage application in cancer immunotherapy Jannie Borst
13:00:00 Cancer Vaccines: Basic strategies and clinical translation
14:00:00 Molecular and metabolic control of adaptive immunity by tumor-induced myelopoiesis Vincenzo Bronte
Tuesday, October 29, 2013
09:00:00 New PNew cell subsets in tumor immune escape and metastasis resentation Xuetao Cao
10:00:00 Merkel cell polyomavirus: a model in tumorigenesis and immunity
11:00:00 Inhibiting co-inhibitors for immunotherapy of cancer Lieping Chen
12:00:00 Disease associated antigens as targets for cancer immunosurvellance and candidates for prophylactic cancer vaccines Olivera J. Finn
13:00:00 An Inducible Cancer Metastatic Niche Mediated by Endothelial STAT3 Xinyuan Fu
14:00:00 Changing tumor microenvironment by local ablative radiation and modified antibody for better immunotherapy Yang-Xin Fu
Wednesday, October 30, 2013
09:00:00 Engineering epitope-optimized AFP-based gene vaccines to prevent autochthonous hepatocellular carcinoma Yukai He
10:00:00 Comparative oncology: Development of xenogenic vaccines and recombinant antibodies for dog mammary cancer patients. Erica Jensen Jarolim
11:00:00 Towards improving immunotherapeutic strategies with human gamma/delta T-cells Dieter Kabelitz
12:00:00 Different tumor immunoenvironments among patients and their modification by molecular targeted therapy Yutaka Kawakami
13:00:00 Danger signal IL-33 and antitumor Immunity
14:00:00 unfolding CD137-based cancer immunotherapy Ignacio Melero
Thursday, October 31, 2013
09:00:00 TLR-ligand peptide conjugates for superior therapeutic vaccination against immunogenic cancers Cornelis J.M. Melief
10:00:00 Oncology meets immunology: targeting PD-L1 in combination Ira Mellman
11:00:00 A Tale with a STING: Pivotal pathways that control immune responses to DNA Andrew Mellor
12:00:00 Immunosenescence and cancer Graham Pawelec
13:00:00 S100A4(FSP-1)promotes liver fibrosis and hepatocellular carcinoma Zhihai Qin
14:00:00 Targeting tumors with genetically enhanced T lymphocytes Michel Sadelain
Friday, November 1, 2013
09:00:00 Receptor ligand interactions that regulate tumor growth and metastases Mark J. Smyth
10:00:00 Adoptive T Cell Therapy of Cancer: Age of Renaissance Cassian Yee
11:00:00 Pathways to Targeting STAT3: Transition into the Clinic Hua Yu
12:00:00 Innate signaling and antigen-specific cancer immunotherapy Rong-Fu Wang
13:00:00 Macrophage Plasticity in Distinct Microenvironments of Human Tumors Limin Zheng
14:00:00 Immune elements shape cancer stemness Weiping Zou
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.